Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal of Medicinal Chemistry
|
July 24, 2020
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
Jonathan T Seal, Stephen J Atkinson, Helen Aylott, et al.
Journal of Crohn'S & Colitis
|
October 11, 2021
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y F Li Yim, et al.
Journal of Medicinal Chemistry
|
July 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors
Jonathan T Seal, Stephen J Atkinson, Paul Bamborough, et al.
The Journal of Clinical Investigation
|
April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
Shane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
Journal of Medicinal Chemistry
|
November 15, 2022
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432
Philip G Humphreys, Niall A Anderson, Paul Bamborough, et al.
Science (New York, N.Y.)
|
March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Journal of Medicinal Chemistry
|
January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate
Philip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal of Medicinal Chemistry
|
July 24, 2020
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
Jonathan T Seal, Stephen J Atkinson, Helen Aylott, et al.
Journal of Crohn'S & Colitis
|
October 11, 2021
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y F Li Yim, et al.
Journal of Medicinal Chemistry
|
July 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors
Jonathan T Seal, Stephen J Atkinson, Paul Bamborough, et al.
The Journal of Clinical Investigation
|
April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
Shane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
Journal of Medicinal Chemistry
|
November 15, 2022
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432
Philip G Humphreys, Niall A Anderson, Paul Bamborough, et al.
Science (New York, N.Y.)
|
March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Journal of Medicinal Chemistry
|
January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate
Philip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Page
of 5